110 related articles for article (PubMed ID: 31408410)
1. Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study.
Sharawat IK; Dawman L; Kumkhaniya MV; Devpura K; Mehta A
Trop Doct; 2019 Oct; 49(4):292-298. PubMed ID: 31408410
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
Cetin N; Gencler A; Sivrikoz IA
Saudi J Kidney Dis Transpl; 2019; 30(4):853-862. PubMed ID: 31464242
[TBL] [Abstract][Full Text] [Related]
3. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
Gulati S; Godbole M; Singh U; Gulati K; Srivastava A
Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
[TBL] [Abstract][Full Text] [Related]
4. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
5. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
[TBL] [Abstract][Full Text] [Related]
7. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
Muske S; Krishnamurthy S; Kamalanathan SK; Rajappa M; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
[TBL] [Abstract][Full Text] [Related]
8. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
Bak M; Serdaroglu E; Guclu R
Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
Banerjee S; Basu S; Sen A; Sengupta J
Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
[TBL] [Abstract][Full Text] [Related]
11. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
Choudhary S; Agarwal I; Seshadri MS
Pediatr Nephrol; 2014 Jun; 29(6):1025-32. PubMed ID: 24414607
[TBL] [Abstract][Full Text] [Related]
12. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in children with steroid-sensitive nephrotic syndrome.
Mishra OP; Meena SK; Singh SK; Prasad R; Mishra RN
Indian J Pediatr; 2009 Dec; 76(12):1237-9. PubMed ID: 19936659
[TBL] [Abstract][Full Text] [Related]
14. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA
N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in children with relapsing nephrotic syndrome: A hospital-based study.
Jesmin T; Al Mamun A; Rahman MA; Santa SM; Huque SS; Begum A; Roy RR; Rahman MH; Uddin GM
Saudi J Kidney Dis Transpl; 2019; 30(6):1415-1422. PubMed ID: 31929289
[TBL] [Abstract][Full Text] [Related]
16. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
Phan V; Blydt-Hansen T; Feber J; Alos N; Arora S; Atkinson S; Bell L; Clarson C; Couch R; Cummings EA; Filler G; Grant RM; Grimmer J; Hebert D; Lentle B; Ma J; Matzinger M; Midgley J; Pinsk M; Rodd C; Shenouda N; Stein R; Stephure D; Taback S; Williams K; Rauch F; Siminoski K; Ward LM;
Osteoporos Int; 2014 Feb; 25(2):627-37. PubMed ID: 23948876
[TBL] [Abstract][Full Text] [Related]
17. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.
Feber J; Gaboury I; Ni A; Alos N; Arora S; Bell L; Blydt-Hansen T; Clarson C; Filler G; Hay J; Hebert D; Lentle B; Matzinger M; Midgley J; Moher D; Pinsk M; Rauch F; Rodd C; Shenouda N; Siminoski K; Ward LM;
Osteoporos Int; 2012 Feb; 23(2):751-60. PubMed ID: 21494860
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.
Ribeiro D; Zawadynski S; Pittet LF; Chevalley T; Girardin E; Parvex P
Eur J Pediatr; 2015 Jul; 174(7):911-7. PubMed ID: 25573461
[TBL] [Abstract][Full Text] [Related]
19. Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study.
Soliman ASA; Abukhatwah MW; Kamal NM; Sweed EMM; Alelyani AM; Althobaiti SD; Alzaedi MA; El-Rebigi AM; Besher NT; Abukhatwah OMW; Alharbi AO; Afifi WE
Medicine (Baltimore); 2022 Aug; 101(33):e29860. PubMed ID: 35984137
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome.
Wetzsteon RJ; Shults J; Zemel BS; Gupta PU; Burnham JM; Herskovitz RM; Howard KM; Leonard MB
J Bone Miner Res; 2009 Mar; 24(3):503-13. PubMed ID: 19016583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]